Genentech

US warns Roche, Shire on misleading drug promotions
Reuters
Thu, 05/6/10 - 08:55 am
Shire
Roche
FDA
warnings
Genentech
Rituxan
Lialda
Pentasa
New licensing chiefs for AZ, Genentech talk deal strategy
Fierce Biotech
Thu, 05/6/10 - 08:52 am
Genentech
licensing
AstraZeneca
BIO
Will Biosimilars Alter Biotech Landscape?
Seeking Alpha
Tue, 05/4/10 - 10:47 am
biotech
biosimilars
FDA
Amgen
Genentech
Genzyme
PDL BioPharma: A Genentech/Roche Buyout Candidate?
Seeking Alpha
Sun, 05/2/10 - 11:12 am
Genentech
Roche
PDL Biopharma
A Genentech Eye Treatment Is Found to Help Prevent Vision Loss in Diabetics
NY Times, NY
Wed, 04/28/10 - 10:55 am
Lucentis
diabetes
Genentech
Biotech's Big Day: The Industry Is Finally Profitable, Mostly Thanks to Cost-Cutting -- Not Higher Sales
BNET Pharma
Wed, 04/28/10 - 07:41 am
earnings
biotech
Roche
Genentech
Hope For Muscular Dystrophy Patients?
Forbes
Sat, 02/27/10 - 11:13 am
Duchenne Muscular Dystrophy
PTC Therapeutics
Genentech
ataluren
Chugai Pharma to develop & commercialize cancer drug GDC-0449 in Japan
Pharmabiz
Sat, 02/20/10 - 11:49 am
Chugai
Curis
Genentech
colorectal cancer
ovarian cancer
Biogen drug OK'd for leukemia treatment
bizjournals.com
Sat, 02/20/10 - 11:01 am
Biogen Idec
Rituxan
Genentech
leukemia
7 Reasons Curis Is Worth the Risk
Seeking Alpha
Fri, 02/19/10 - 09:26 am
Curis
Genentech
CompuGen
Cepheid
Roche Second-Half Profit Rises on Genentech Savings
Bloomberg
Wed, 02/3/10 - 07:48 am
Roche
Genentech
earnings
Digging Deeper into Adventrx Pharmaceuticals
TheStreet.com
Tue, 01/19/10 - 09:40 am
Adventrx
Genentech
Novartis
Amgen
Pfizer
Novelos Therapeutics
ONYX Pharmaceuticals
FDA Extends Review Period for Tarceva Application for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer
Yahoo/BusinessWire
Sat, 01/16/10 - 11:08 am
Tarceva
OSI Pharmaceuticals
Genentech
Roche
Notes From JP Morgan: Rochentech
InVivo
Tue, 01/12/10 - 10:09 am
Roche
Genentech
biotech
Roche, Genentech try to calm jittery partners
Fierce Biotech
Tue, 12/22/09 - 08:06 am
Roche
Genentech
M&A
Panel Rejects Early Use of Tarceva
WSJ Online
Thu, 12/17/09 - 08:56 am
Tarceva
OSI Pharmaceuticals
FDA
lung cancer
Roche
Genentech
Nexavar, Herceptin could gain from cancer meeting
Fierce Pharma
Mon, 12/14/09 - 06:14 pm
Nexavar
Herceptin
Genentech
breast cancer
Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab
PR-Canada
Sun, 12/13/09 - 12:20 pm
Roche
Genentech
Biogen Idec
ocrelizumab
Genentech sheds pact as pipeline review claims another deal
Fierce Biotech
Fri, 12/11/09 - 10:31 am
pipelines
Genentech
Roche
Seattle Genetics
partnerships
More from Genentech's McCracken on the Future of Pharmaceutical Sales
BNET Pharma
Tue, 12/8/09 - 11:14 am
pharmaceutical sales
Genentech
pharma industry

Pages